Trial Profile
Platelet Reactivity After Switching from Clopidogrel to Prasugrel in Chronic hemodialysis Patients with Coronary Artery Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Nov 2017
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 30 Oct 2017 Status changed from recruiting to completed.
- 15 Jul 2016 New trial record